E2F1 and Dravet syndrome: In the DS group, the expression levels of both E2F1, c-MYC mRNAs and miR-17, miR-18a, miR-106a were up-regulated, indicating that in patients with DS, the proliferation and apoptosis of APL cells in peripheral blood were enhanced and the differentiation was attenuated.